| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13241* | 2021 |
| Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model J Kota, RR Chivukula, KA O'Donnell, EA Wentzel, CL Montgomery, ... Cell 137 (6), 1005-1017, 2009 | 2118 | 2009 |
| Eteplirsen for the treatment of Duchenne muscular dystrophy JR Mendell, LR Rodino‐Klapac, Z Sahenk, K Roush, L Bird, LP Lowes, ... Annals of neurology 74 (5), 637-647, 2013 | 853 | 2013 |
| Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver S Hsu, B Wang, J Kota, J Yu, S Costinean, H Kutay, L Yu, S Bai, ... The Journal of clinical investigation 122 (8), 2871-2883, 2012 | 845 | 2012 |
| Gentamicin‐induced readthrough of stop codons in Duchenne muscular dystrophy V Malik, LR Rodino‐Klapac, L Viollet, C Wall, W King, R Al‐Dahhak, ... Annals of neurology 67 (6), 771-780, 2010 | 367 | 2010 |
| Sustained alpha‐sarcoglycan gene expression after gene transfer in limb‐girdle muscular dystrophy, type 2D JR Mendell, LR Rodino‐Klapac, XQ Rosales, BD Coley, G Galloway, ... Annals of neurology 68 (5), 629-638, 2010 | 284 | 2010 |
| Limb‐girdle muscular dystrophy type 2D gene therapy restores α‐sarcoglycan and associated proteins JR Mendell, LR Rodino‐Klapac, X Rosales‐Quintero, J Kota, BD Coley, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 263 | 2009 |
| Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease LR Rodino‐Klapac, AM Haidet, J Kota, C Handy, BK Kaspar, JR Mendell Muscle & Nerve: Official Journal of the American Association of …, 2009 | 240 | 2009 |
| Follistatin gene delivery enhances muscle growth and strength in nonhuman primates J Kota, CR Handy, AM Haidet, CL Montgomery, A Eagle, ... Science translational medicine 1 (6), 6ra15-6ra15, 2009 | 220 | 2009 |
| A systematic review of miR-29 in cancer JJ Kwon, TD Factora, S Dey, J Kota Molecular Therapy-Oncolytics 12, 173-194, 2019 | 198 | 2019 |
| Pancreatic cancer: Stroma and its current and emerging targeted therapies J Kota, J Hancock, J Kwon, M Korc Cancer letters 391, 38-49, 2017 | 175 | 2017 |
| EZH2 modifies sunitinib resistance in renal cell carcinoma by kinome reprogramming R Adelaiye-Ogala, J Budka, NP Damayanti, J Arrington, M Ferris, CC Hsu, ... Cancer research 77 (23), 6651-6666, 2017 | 73 | 2017 |
| Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential JJ Kwon, JA Willy, KA Quirin, RC Wek, M Korc, XM Yin, J Kota Oncotarget 7 (44), 71635, 2016 | 70 | 2016 |
| Pathophysiological role of microRNA-29 in pancreatic cancer stroma JJ Kwon, SC Nabinger, Z Vega, SS Sahu, RK Alluri, Z Abdul-Sater, Z Yu, ... Scientific reports 5 (1), 11450, 2015 | 69 | 2015 |
| Impaired regeneration in LGMD2A supported by increased PAX7‐positive satellite cell content and muscle‐specific microrna dysregulation XQ Rosales, V Malik, A Sneh, L Chen, S Lewis, J Kota, JM Gastier‐Foster, ... Muscle & nerve 47 (5), 731-739, 2013 | 33 | 2013 |
| miR-29a is repressed by MYC in pancreatic cancer and its restoration drives tumor-suppressive effects via downregulation of LOXL2 S Dey, JJ Kwon, S Liu, GA Hodge, S Taleb, TA Zimmers, J Wan, J Kota Molecular Cancer Research 18 (2), 311-323, 2020 | 29 | 2020 |
| Safety and efficacy of AAV retrograde pancreatic ductal gene delivery in normal and pancreatic cancer mice KA Quirin, JJ Kwon, A Alioufi, T Factora, CJ Temm, M Jacobsen, ... Molecular therapy Methods & clinical development 8, 8-20, 2018 | 29 | 2018 |
| Loss of miR-29a/b1 promotes inflammation and fibrosis in acute pancreatitis S Dey, LM Udari, P RiveraHernandez, JJ Kwon, B Willis, JJ Easler, ... JCI insight 6 (19), 2021 | 26 | 2021 |
| Compositions and methods for treating hepatic neoplasia JT Mendell, KA Mendell, RR Chivukula, EA Wentzel, JR Mendell, ... US Patent 8,729,041, 2014 | 18 | 2014 |
| Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment S Dey, S Liu, TD Factora, S Taleb, P Riverahernandez, L Udari, X Zhong, ... BMC cancer 20, 1-13, 2020 | 16 | 2020 |
